An overview of randomized clinical trials in metastatic breast cancer: variables affecting regulatory drug approval

The aim of this study was to analyse trial variables affecting drug approval in metastatic breast cancer (MBC). A literature search from 2000 to 2012 retrieved 66 phase III randomized controlled trials with reported primary endpoints in MBC and known outcomes in terms of approval. The influence of t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Anti-cancer drugs 2014-10, Vol.25 (9), p.992-997
Hauptverfasser:	Conde-Estévez, David, Tusquets, Ignasi, Servitja, Sonia, Martínez-García, María, Salas, Esther, Albanell, Joan
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Breast Neoplasms - drug therapy Breast Neoplasms - pathology Clinical Trials, Phase III as Topic Disease Progression Disease-Free Survival Drug Approval Female Humans Neoplasm Metastasis Randomized Controlled Trials as Topic Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!